Emergent BioSolutions

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EBS and other ETFs, options, and stocks.

About EBS

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. 

CEO
Joseph C. Papa
CEOJoseph C. Papa
Employees
900
Employees900
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1998
Founded1998
Employees
900
Employees900

EBS Key Statistics

Market cap
577.19M
Market cap577.19M
Price-Earnings ratio
8.49
Price-Earnings ratio8.49
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$11.47
High today$11.47
Low today
$10.90
Low today$10.90
Open price
$11.05
Open price$11.05
Volume
1.73M
Volume1.73M
52 Week high
$14.06
52 Week high$14.06
52 Week low
$4.02
52 Week low$4.02

Stock Snapshot

Emergent BioSolutions(EBS) stock is priced at $11.06, giving the company a market capitalization of 577.19M. It carries a P/E multiple of 8.49.

During the trading session on 2026-01-19, Emergent BioSolutions(EBS) shares reached a daily high of $11.47 and a low of $10.90. At a current price of $11.06, the stock is +1.5% higher than the low and still -3.6% under the high.

Trading activity shows a volume of 1.73M, compared to an average daily volume of 1.16M.

Over the past 52 weeks, Emergent BioSolutions(EBS) stock has traded between a high of $14.06 and a low of $4.02.

Over the past 52 weeks, Emergent BioSolutions(EBS) stock has traded between a high of $14.06 and a low of $4.02.

EBS News

Benzinga 3d
Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading

Emergent BioSolutions Inc. (NYSE:EBS) stock rose in Friday premarket trading. On Thursday, New York Attorney General Letitia James sued former chief executive...

Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading
The Wall Street Journal 4d
NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading

Robert Kramer retired as CEO of Emergent BioSolutions in 2023. pool/Reuters New York Attorney General Letitia James filed suit against the former head of Emerg...

NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading
TipRanks 5d
Emergent BioSolutions outlines transformation and financial guidance at conference

Claim 70% Off TipRanks Premium An update from Emergent Biosolutions ( (EBS) ) is now available. On January 14, 2026, Emergent BioSolutions president and chief...

More EBS News

Simply Wall St 5d
Investors five-year losses continue as Emergent BioSolutions dips a further 7.5% this week, earnings continue to decline

While it may not be enough for some shareholders, we think it is good to see the Emergent BioSolutions Inc. ( ) share price up 27% in a single quarter. But will...

Investors five-year losses continue as Emergent BioSolutions dips a further 7.5% this week, earnings continue to decline

People also own

Based on the portfolios of people who own EBS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .